BA vs ECG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Boeing exhibits severe fundamental distress, characterized by a stable but mediocre Piotroski F-Score of 4/9 and a massive valuation gap, with the current price ($219.16) trading at a staggering premium over its Graham Number ($19.68) and Intrinsic Value ($17.36). While revenue growth is robust at 57.10%, the company suffers from negative operating margins and a dangerous Debt/Equity ratio of 10.33. The combination of bearish insider sentiment, a 0/100 technical trend, and poor liquidity (Quick Ratio 0.38) outweighs the optimistic analyst price targets.
ECG exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and impressive growth metrics, including 60.2% YoY earnings growth. However, the stock is significantly overvalued, trading at $136.06—well above its Graham Number ($33.13) and Intrinsic Value ($116.53). While profitability is strong with an ROE of 38.34%, the technical trend is heavily bearish (10/100), suggesting the recent 232% one-year rally may have peaked. The valuation premium is high, and the current price exceeds the analyst target of $131.50.
Compare Another Pair
BA vs ECG: Head-to-Head Comparison
This page compares The Boeing Company (BA) and Everus Construction Group, Inc. (ECG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.